GSK621

GSK621

Stock Code: 3575679
Manufacturer Part No: SML2003-25MG
Order Now for 7 day delivery
£671.36 (exc VAT) per 25MG
Quantity: - +

Application


GSK621 has been used as an AMP-activated kinase ? (AMPK ?) activator to study the antiviral role of AMPK in Zika virus (ZIKV) infection. It has also been used as an AMPK ? activator to study its protective effect on myocardial cells against oxygen-glucose deprivation-re-oxygenation (OGD/R).


Biochem/physiol Actions


GSK621 is a direct AMPK activator that exhibits anti-leukemic (300 µM; MOLM-14, HL-60, OCI-AML3) and anti-glioma (Effec. conc. 10-100 µM; U87MG and U251MG) activity, while displaying little cytotoxicity toward normal hematopoietic progenitors, primary human astrocytes, or HCN-1a neuronal cells. When administered via intraperitoneal injection, GSK621 (30 mg/kg twice daily) is shown to reduce leukemia growth and significantly extend the survival of mice xenografted with MOLM-14 cells. AMPK activation by GSK621 leads to mTOR inhibition and Tetraspanin 8 (Tspan8) downregulation in glioma cells, while GSK621-induced cytotoxicity in acute myeloid leukemia (AML) cells is the result of synthetic lethality, where co-activation of AMPK and mTORC1 activates the eIF2a signaling pathway, which in turn triggers autophagic cell death.

Colourwhite to beige
ManufacturerSIGMA-ALDRICH
Storage Temp.2-8°C
SolubilityDMSO: 2 mg/mL, clear
Formpowder
Assay≥98% (HPLC)

There are no downloads for this product.